Literature DB >> 9263278

Glutamine dipeptides in clinical nutrition.

P Fürst1, K Pogan, P Stehle.   

Abstract

Glutamine is a conditional indispensable amino acid during stress. However, limited solubility and instability of glutamine prevent its addition to presently available nutritional preparations. To overcome these drawbacks, we propose the dipeptide concept by which stable and highly soluble synthetic glutamine containing dipeptides are used. The synthetic dipeptides fulfill all chemical/physical properties to be considered as parenteral substrates. Numerous experimental studies show rapid clearance of parenteral supplied glutamine containing dipeptides without accumulation in tissues; the loss via the urine being inconsequential. Differences related to the dipeptide structure are not observed. There is overwhelming evidence existent that a nutritional support with supplemental glutamine dipeptide positively influences nitrogen excretion, immune status, gut integrity, morbidity, rehabilitation and outcome. Consequently, omission of glutamine from conventional TPN and its subsequent administration should be considered as a replacement of a deficiency rather than a supplementation. It might thus be conceivable that the beneficial effects observed with glutamine nutrition are simply a correction of disadvantages produced by an inadequacy of conventional amino acid solutions. The availability of stable glutamine containing preparations will certainly facilitate an adequate amino acid nutrition in routine clinical setting during episodes of stress and malnutrition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9263278     DOI: 10.1016/s0899-9007(97)83035-3

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  15 in total

1.  Total parenteral nutrition with glutamine dipeptide shortened hospital stays and improved immune status and nitrogen economy after major abdominal surgery.

Authors:  J Powell-Tuck
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

2.  A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition.

Authors:  J Powell-Tuck; C P Jamieson; G E Bettany; O Obeid; H V Fawcett; C Archer; D L Murphy
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Glutamine dipeptide for parenteral nutrition in abdominal surgery: a meta-analysis of randomized controlled trials.

Authors:  Ya-Min Zheng; Fei Li; Ming-Ming Zhang; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 4.  Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.

Authors:  Katharina S Kuhn; Maurizio Muscaritoli; Paul Wischmeyer; Peter Stehle
Journal:  Eur J Nutr       Date:  2009-11-21       Impact factor: 5.614

5.  Acute alcohol exposure, acidemia or glutamine administration impacts amino acid homeostasis in ovine maternal and fetal plasma.

Authors:  Shannon E Washburn; Onkar B Sawant; Emilie R Lunde; Guoyao Wu; Timothy A Cudd
Journal:  Amino Acids       Date:  2013-01-12       Impact factor: 3.520

6.  Fermentative production of L-alanyl-L-glutamine by a metabolically engineered Escherichia coli strain expressing L-amino acid alpha-ligase.

Authors:  Kazuhiko Tabata; Shin-Ichi Hashimoto
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

7.  N-acetyl-L-glutamine, a liquid-stable source of glutamine, partially prevents changes in body weight and on intestinal immunity induced by protein energy malnutrition in pigs.

Authors:  José M López-Pedrosa; Manuel Manzano; Jeffrey H Baxter; Ricardo Rueda
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

8.  Brief Glutamine Pretreatment Increases Alveolar Macrophage CD163/Heme Oxygenase-1/p38-MAPK Dephosphorylation Pathway and Decreases Capillary Damage but Not Neutrophil Recruitment in IL-1/LPS-Insufflated Rats.

Authors:  Ana Fernandez-Bustamante; Amanda Agazio; Paul Wilson; Nancy Elkins; Luke Domaleski; Qianbin He; Kaily A Baer; Angela F D Moss; Paul E Wischmeyer; John E Repine
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  MicroRNAs: a novel promising therapeutic target for cerebral ischemia/reperfusion injury?

Authors:  Xiao-Li Min; Ting-Yong Wang; Yi Cao; Jia Liu; Jin-Tao Li; Ting-Hua Wang
Journal:  Neural Regen Res       Date:  2015-11       Impact factor: 5.135

10.  Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats.

Authors:  Carlos Vinicius D da Rosa; Silvia C S F Azevedo; Roberto B Bazotte; Rosane M Peralta; Nilza C Buttow; Maria Montserrat D Pedrosa; Vilma A F de Godoi; Maria Raquel M Natali
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.